What is a clinical trial? Is participating in a clinical trial right for you? Learn more
Urothelial Carcinoma of the Bladder Clinical Trial in Philadelphia PA
Have you or your loved ones been diagnosed with urothelial carcinoma of the bladder?
You may be eligible to participate in a urothelial carcinoma of the bladder clinical trial.
Have you or your loved ones been diagnosed with urothelial carcinoma of the bladder? You may be eligible to participate in a urothelial carcinoma of the bladder clinical trial.
Active not recruiting
Male & Female
18 Years +
The aim of this study is to evaluate a risk-adapted approach to the treatment of muscle invasive bladder cancer. Each baseline transuretheral resection of bladder tumor (TURBT) sample will be sequenced while proceeding with neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) chemotherapy. Based on the mutational profile and the post AMVAC TURBT findings, patients will be treated with active surveillance (experimental arm), or standard of care intravesicle therapy, chemoradiation or surgery. We hypothesize that this approach will lead to non-inferior metastasis-free survival at 2 years, while preserving the bladder and thus quality-of-life for a proportion of patients.